Jose Antonio López Escámez is appointed new scientific director of the ibs.GRANADA
The renowned researcher of Meniere's disease, Dr. López Escámez, is appointed new scientific director of the Biosanitary Research Institute of Granada (ibs.GRANADA), approved in the last governing council of May 14.
Dr. López Escámez takes over from Dr. Nicolás Olea, who among his main achievements as scientific director has been to successfully lead the accreditation of ibs.GRANADA by the Carlos III Health Institute (ISCIII), which has meant a significant increase in attracting competitive funds for research. Dr. Olea is Professor of the Department of Radiology at the University of Granada and FEA of the UGC of Nuclear Medicine of the San Cecilio University Hospital of Granada.
José Antonio López Escámez is a Doctor of Medicine and Surgery from the University of Granada, and a Master in Clinical Genetics. His predoctoral and postdoctoral training was completed in London and Ann Arbor, Michigan investigating the mechanisms of ototoxicity of the vestibular system. After this period, he performed the MIR in Otorhinolaryngology at the Virgen de las Nieves Hospital and became FEA at the Poniente Hospital.
Currently, he is the principal investigator of the Otology and Otoneurology Group of the ibs.GRANADA, which he shares with the healthcare activity as a Physician
Specialist in Otolaryngology at the Virgen de las Nieves University Hospital in Granada, dedicating himself to the study of Meniere's disease. He is the coordinator of the International Meniere Disease Consortium, which is part of a network of centers in Europe for the study of Meniere. It has a total of 118 publications including book chapters, 2100 citations and 4 supervised doctoral theses.
About ibs.GRANADA
The Instituto de Investigación Biosanitaria ibs.GRANADA has been configured as an integrating space for biomedical research in Granada. The ibs.GRANADA is structured in five Scientific Areas and three Technological Platforms that have made possible a very relevant cooperative scientific production, the provision of technical services to the groups that make them up and the transfer of research results to the society in which it integrates.
Currently, there are 80 multidisciplinary research groups that make up the Institute, mainly from the Virgen de las Nieves University Hospital, San Cecilio University Hospital, the University of Granada, research centers of the Ministry of Health and Primary Care.
The Institute brings together more than 950 professionals, and develops six main lines of Scientific and Technological Research and Innovation related to the areas of knowledge of: Cancer, Systemic, neurological and cardiovascular diseases, Hepatic, digestive and infectious diseases, Endocrine and metabolic diseases and Health Technologies. The structure is completed by four technological platforms: Biobank and Disease Registry, Clinical Epidemiology and Support for Clinical Trials, Scientific-Technical Platform, and Technology Transfer and Innovation Platform.
The main objectives of the ibs.GRANADA are to promote biomedical, clinical and epidemiological research carried out by the different groups attached to the institute, and to promote translational research. This type of research activity translates into the generation of knowledge and the transfer of scientific advances towards the prevention, diagnosis and treatment of priority health problems in Andalusia.